[The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma].
Kliesch
S
S
Klinik und Poliklinik für Urologie, Westfälische Wilhelms-Universität Münster. S.Kliesch@uni-muenster.de
Behre
H M
HM
Roth
S
S
D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D002277:Carcinoma / Q000150:complications* / Q000188:drug therapy; D004054:Diethylstilbestrol / Q000009:adverse effects*; D005483:Flushing / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects* / Q000819:agonists; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D004054:Diethylstilbestrol